NCT05087667 Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
| NCT ID | NCT05087667 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Quanta Medical |
| Condition | Femoral Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 202 participants |
| Start Date | 2022-03-08 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 202 participants in total. It began in 2022-03-08 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The use of cerclage wiring in the management of long bone fractures is common. With the increase in the placement of total hip ans shoulder prostheses, the occurrence of peri-prosthetic hip an shoulder fractures is also increasing, notably due to an older population. Whether it is for a fracture on a native femur or humerus, or on a periprosthetic hip or shoulder fracture, the use of cerclage wiring is an adjuvant additional but not the main means to ensure stable osteosynthesis, allowing re-loading and early rehabilitation of patients. This method has demonstrated its ability to improve the fixation of this fracture type, associated with osteosynthesis or hip/shoulder prosthesis revision surgery. However, metal cerclage expose to a risk of metallosis which can compromise bone fusion, injury to neighboring soft parts causing pain and also injury to the surgical team when handling them. More recently, non-metallic cerclage have been developed and could overcome certain risks associated with metallic cerclage, while ensuring their bone fixing capacity and therefore bone consolidation. Indeed, non-metallic cerclage could withstand similar or even greater stresses than metallic cables, in particular concerning their resistance to rupture. The "Sterile Self Locking Polymer Cerclage System" named OrthoLoop is a polymer cerclage which has been developed and could be used in these indications. Thus, this study (SERRE) aims to investigate the clinical results and sequelae of adjuvant cerclage wires OrthoLoop Cerclage in the management of rehabilitation, per prosthetic or primary femoral or humeral fractures compared with cerclages system used in standard care. SERRE is a 36 months follow up study in two arms : * Experimental group: "OrthoLoop cercalge" * Control group: "cerclages used in standard care" After each surgery, the patient follow-up period is 36 months. with 4 planned consultation visits after surgery at 6-8 weeks, 3, 6 and 36 months, with collection and measurement of the endpoints. The main objective of this study is to assess the role of "OrthoLoop cerclage" of COUSIN Biotech in comparison with cerclages (metallic for the majority) used in standard care ; in the optimization of the consolidation of primary and periprosthetic femoral or humeral fractures, 6 months after surgery.
Eligibility Criteria
Inclusion Criteria: * patient with femoral or humeral fracture requiring the installation of one or more cerclage(s) and respecting at least one of the criteria below: * Primary femoral or humeral fractures (diaphyseal, metaphyseal, epiphyseal proximal or distal) with osteosynthesis by plate and screw or osteosynthesis by Intramedullary nailing associated with the installation of one or more cerclage(s) * Patients with traumatic fracture of femur or humerus that required prosthetic rehabilitation associated with the installation of one or more cerclage(s) * Peri-prosthetic fracture of the femur or humerus * Resumption of prosthesis (hip, knee, shoulder, elbow) requiring the installation of one or more cerclages * who underwent fixation with cerclage wiring (Sterile Self Locking Polymer Cerclage System or other cerclage systems used in standard care) * age ≥18 years * Who have given free, informed and written consent to participate in the study * Patient able to communicate in French * Patient affiliated to a social security system or entitled to a social security system Exclusion Criteria: * high-energy injury, * associated damage to other long bones, * fracture extension to the articular surface with displacement * Severe disease that could interfere with the study results or be life threatening * Patients with an infection * Allergy to any component of the medical products * Pregnant or breastfeeding women * Anticipated unavailability during the study * Participation in a clinical trial within 3 months prior to the inclusion visit. * Patient with linguistic or psychological incapacity to understand and sign the informed consent. * Patient deprived of liberty by administrative or judicial decision, or being under guardianship.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05087667 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Femoral Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05087667 currently recruiting?
Yes, NCT05087667 is actively recruiting participants. Contact the research team at b.hill@quanta-medical.com for enrollment information.
Where is the NCT05087667 trial being conducted?
This trial is being conducted at Agen, France, Périgueux, France, Tourcoing, France, Lille, France and 11 additional locations.
Who is sponsoring the NCT05087667 clinical trial?
NCT05087667 is sponsored by Quanta Medical. The trial plans to enroll 202 participants.